The historical rank and industry rank for Armata Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Armata Pharmaceuticals's highest Price to Tangible Book Ratio was 38.24. The lowest was 1.21. And the median was 7.18.
ARMP's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.7 * Ranked among companies with meaningful Price-to-Tangible-Book only.
Armata Pharmaceuticals Price-to-Tangible-Book Historical Data
The historical data trend for Armata Pharmaceuticals's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Armata Pharmaceuticals Price-to-Tangible-Book Chart
Competitive Comparison of Armata Pharmaceuticals's Price-to-Tangible-Book
For the Biotechnology subindustry, Armata Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Armata Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Armata Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Armata Pharmaceuticals's Price-to-Tangible-Book falls into.
Armata Pharmaceuticals Price-to-Tangible-Book Calculation
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Armata Pharmaceuticals Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Armata Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Armata Pharmaceuticals (Armata Pharmaceuticals) Business Description
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. It is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent. Further, the company is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARMP has been successfully added to your 